Q1 FY2025 Earnings
Financial report interval: 2024.12.31 - 2025.03.31
Overview: Glycomimetics(GLYC) the EBIT is -2.399 M (+78.42%);the EPS is -3.63 (+78.19%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B78.42%
----
----
EPS
-3.632478.19%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf